Selank + Semax
Single vial containing 10mg Selank + 10mg Semax — combined anxiolytic and nootropic neuropeptide research
Select size
For research purposes only. Not for human consumption.
Mechanism of Action
A combined neuropeptide research vial containing 10mg Selank and 10mg Semax in a single preparation. Selank modulates GABAergic and serotonergic systems for anxiolytic effects, while Semax upregulates BDNF and NGF expression for neuroprotection and cognitive enhancement.
How It Works
- 1
Selank (10mg) modulates GABA and serotonin neurotransmission for anxiolytic activity
- 2
Semax (10mg) upregulates BDNF and NGF expression in cortex and hippocampus
- 3
Both peptides stabilize enkephalins and modulate dopaminergic pathways
- 4
Combined preparation simplifies dosing for parallel anxiolytic and nootropic research
Key Research Benefits
- Anxiolytic + nootropic in one vial
- BDNF/NGF upregulation
- GABAergic modulation
- Cognitive enhancement studies
Single-vial combination of two complementary neuropeptides — Selank for anxiolytic GABA modulation and Semax for BDNF-driven neuroprotection — frequently paired in cognitive and neurobehavioral research.